Financials Shanghai HeartCare Medical Technology Corporation Limited

Equities

6609

CNE100004MN5

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E. 04:09:00 2024-05-03 am EDT 5-day change 1st Jan Change
19.36 HKD +7.92% Intraday chart for Shanghai HeartCare Medical Technology Corporation Limited +8.04% -34.92%

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 3,316 1,252 1,031 684.1 - -
Enterprise Value (EV) 1 2,140 427.1 445.5 210.9 319.7 374.3
P/E ratio -14.7 x -6.19 x -10.9 x 897 x 18.7 x -
Yield - - - - - -
Capitalization / Revenue 36.8 x 6.84 x 4.44 x 2 x 1.48 x 1.32 x
EV / Revenue 23.8 x 2.33 x 1.92 x 0.62 x 0.69 x 0.72 x
EV / EBITDA -11.7 x -2.49 x -5.45 x 22.1 x 6.52 x 4.21 x
EV / FCF - - - - - -
FCF Yield - - - - - -
Price to Book 2.08 x - - 0.65 x 0.63 x -
Nbr of stocks (in thousands) 38,834 38,560 38,142 38,141 - -
Reference price 2 85.39 32.46 27.04 17.94 17.94 17.94
Announcement Date 3/28/22 3/20/23 3/28/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 - 90.09 183 232.3 342.3 461.9 518.8
EBITDA 1 - -183.3 -171.2 -81.7 9.547 49.01 88.88
EBIT 1 - -195.5 -199.1 -114 -16.01 22.05 47.29
Operating Margin - -217.05% -108.78% -49.05% -4.68% 4.77% 9.11%
Earnings before Tax (EBT) 1 - -197.9 - -102.9 1 44 -
Net income 1 -213.7 -194.2 - -94.01 1 37 94
Net margin - -215.59% - -40.46% 0.29% 8.01% 18.12%
EPS 2 -9.780 -5.820 -5.240 -2.470 0.0200 0.9600 -
Free Cash Flow - - - - - - -
FCF margin - - - - - - -
FCF Conversion (EBITDA) - - - - - - -
FCF Conversion (Net income) - - - - - - -
Dividend per Share - - - - - - -
Announcement Date 8/10/21 3/28/22 3/20/23 3/28/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2 2024 S1 2024 S2
Net sales 1 59.96 76.71 106.3 109.6 122.8 145.3 188.3
EBITDA - - - - - - -
EBIT 1 -103.1 -84.32 -133.3 -61.61 -52.35 -11.14 -8.881
Operating Margin -171.96% -109.91% -125.37% -56.22% -42.64% -7.67% -4.72%
Earnings before Tax (EBT) - - - - - - -
Net income - -66.82 - - - - -
Net margin - -87.1% - - - - -
EPS - -1.750 - - - - -
Dividend per Share - - - - - - -
Announcement Date 3/28/22 8/31/22 3/20/23 8/31/23 3/28/24 - -
1CNY in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - -
Net Cash position 1 - 1,176 824 586 473 364 310
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow - - - - - - -
ROE (net income / shareholders' equity) - -18.9% - - 0.1% 3.4% -
ROA (Net income/ Total Assets) - -17.1% - - 0.1% 2.8% -
Assets 1 - 1,139 - - 1,000 1,321 -
Book Value Per Share 2 - 41.10 - - 27.60 28.60 -
Cash Flow per Share 2 - -6.160 - - -1.180 -2.080 -
Capex 1 - 52.8 - - 70 70 -
Capex / Sales - 58.65% - - 20.45% 15.16% -
Announcement Date 8/10/21 3/28/22 3/20/23 3/28/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
17.94 CNY
Average target price
27.12 CNY
Spread / Average Target
+51.19%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 6609 Stock
  4. Financials Shanghai HeartCare Medical Technology Corporation Limited